Add like
Add dislike
Add to saved papers

Microdebrider-assisted versus radiofrequency-assisted inferior turbinoplasty.

Laryngoscope 2009 Februrary
OBJECTIVES: The study aimed to evaluate the long-term efficacy of microdebrider-assisted inferior turbinoplasty (MAIT) compared to radiofrequency-assisted inferior turbinoplasty (RAIT) for hypertrophic inferior turbinates.

STUDY DESIGN: Surgical outcomes were evaluated using the visual analogue scale, anterior rhinomanometry, and saccharin test results.

METHODS: From January 2001 to December 2006 inclusively, 120 patients with persistent allergic rhinitis, chronic nasal obstruction, and hypertrophic inferior turbinates were enrolled in this study, randomly classified, and underwent either MAIT (n = 60) or RAIT. Ten patients who did not have any nasal discomfort served as normal controls. Assessments (visual analogue scale, anterior rhinomanometry, and saccharin test) were conducted prior to surgery and 6 months, 1, 2, and 3 years subsequent to surgery.

RESULTS: Compared to preoperative values, the symptom scores (nasal obstruction, sneezing, rhinorrhea, and snoring), mean total nasal resistance, and mean saccharin transit time all improved significantly at 6 months, 1, 2, and 3 years after surgery in MAIT group (P < .05 for all). The same holds true for the RAIT group from 6 months up to 1 year (P < .05 for all), but no improvements from 2 to 3 years after were noted. The parameters between the two groups did not significantly differ 6 months after surgery, but was noted after 1 to 3 years (P < .05 for all).

CONCLUSION: MAIT is more effective than RAIT at relieving nasal symptoms and decreasing total nasal resistance and saccharin transit time 1 to 3 years postoperatively in patients with persistent allergic rhinitis and who have substantial nasal obstruction.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app